Punjab Chemicals & Crop Protection Ltd

- Punjab Chemicals and Crop Protection Ltd plans to fund its upcoming CAPEX partly through internal accruals and partly through debt. - The exact timing and requirement for debt will depend on the project timelines. - Management is also exploring other options for raising funds but no definitive decision on equity issuance has been mentioned. - Any updates on fundraising solutions will be communicated at the appropriate time. - There is no explicit mention of any immediate equity fundraising in the current discussion.

- Punjab Chemicals and Crop Protection Ltd is investing in new production blocks and asset renewal to support product demand and new product commercialization. - Current year CAPEX is estimated at Rs. 35-40 crores, including around Rs. 10-15 crores for new block construction. - Asset renewal expenses approximate Rs. 20-25 crores annually. - A Greenfield CAPEX plan is underway with a targeted investment of about Rs. 350 crores over three years for a new manufacturing site. - The company plans phased capital outlay for the new site, expected to be finalized within two quarters. - Funding for CAPEX will be partly through internal accruals and partly debt, with management exploring additional financing options. - Brownfield expansions and de-bottlenecking of existing plants will cater to near-term capacity requirements before new plants are commissioned.

- Punjab Chemicals expects overall revenue growth of 15% to 20% year-on-year for the current and next financial years (FY26 and FY27). - Export markets, including Europe, Japan, and the US, are seeing rising demand with stable pricing; exports have grown about 10% year-on-year recently. - New product commercialization is expected to contribute significantly, with five products set to be commercialized in FY27, leading to increased sales and improved margins. - The company anticipates increasing new product share from 12% to about 16% of revenue, with further growth expected. - Domestic demand is stable but impacted temporarily by unseasonal rains; export growth is expected to compensate for any domestic shortfall. - Long-term revenue guidance for FY27 is around Rs. 1200 crores with an EBITDA margin target of 16% to 18%. - Expansion plans include Brownfield de-bottlenecking and a potential Greenfield plant with a capex of about Rs. 350 crores over three years.

- The company targets 15% to 20% year-on-year revenue growth for FY26 and expects to maintain this trajectory into FY27, aiming for around Rs. 1200 crores revenue in FY27. - EBITDA margins are projected to improve gradually from 11.5%-12.5% in FY26 towards a long-term target of 16%-18%. - Improvement levers include new product introductions with higher margins, enhanced process efficiencies, and backward integration to reduce costs. - New products' contribution is increasing, with 16% revenue share in H1 FY26, expected to grow further, supporting margin expansion. - Export demand revival, stable pricing, and better product mix are expected to drive sustainable earnings growth. - Strategic CAPEX investments (about Rs. 350 crores over 3 years) in new production blocks and sites will support capacity expansion and future growth. - Tax rate is stable at an effective rate of around 25%, aiding profit stability.

- The company signed three new MOUs for export-oriented products. - Expected revenue potential from these three MOUs is about Rs. 125 to 150 crores once products fully mature and stabilize. - The product cycle includes sample approval, batch analysis, and product registration, which takes time. - The company is on track to commercialize five new products in FY26, with two already commercialized in the first half. - Demand and market acceptance for these new products are positive, with further campaigns planned next year. - They are planning capacity expansion through de-bottlenecking existing plants and new production blocks to support increasing demand. - Discussions are ongoing for a new site for future growth with an anticipated CAPEX of about Rs. 350 crores over three years, expected to be finalized in the next two quarters.